Research Labs

  • The Aggarwal Lab evaluates the risk of cardiovascular disease and sleep patterns in a diverse population of women in various life stages

  • Dr. Area-Gomez's lab is currently researching how C99 contributes to the regulation of lipid homeostasis, and how the alteration in the level of C99 in MAMs plays a role in the pathogenesis of AD.

  • The Bauer Lab uses a mix of molecular biology, animal physiology, and functional genomics to translate human genetics studies into actionable biological mechanisms.

  • Dr. Chang’s research is focused on understanding how bioactive lipid mediators modulate innate immune cell biology

  • Dr. Diano’s research focuses on intracellular nutrient sensing mechanisms in brain cells regulating energy and glucose metabolism, and how their derangement promotes development of metabolic disorders

  • The Embree Lab conducts cutting edge biomedical research in the field of regenerative medicine with the goal of translating science into clinical practice

  • Work in Dr. Ferrante's laboratory currently focuses on identifying the ontogeny of sub-populations of macrophages and their specific roles.

  • Haeusler Lab's research goals are to understand the development of proatherogenic metabolic abnormalities in insulin resistant individuals, and to identify new therapeutic targets for improving these.

  • The Margolis Lab studies the effects of neurotransmitters and inflammation on enteric nervous system development and function

  • The Pajvani Lab's research interests intersect the diverse fields of development, metabolism and cancer biology, by study of the Notch signaling pathway.

  • Dr. Pon's lab studies the mechanism underlying the processes described below, how they affect lifespan and change as yeast cells age, and whether modulation of those processes can extend lifespan.

  • The Reilly Group at the Columbia University Irving Medical Center is dedicated to translational and genomic studies of human cardiometabolic disorders.

  • Dr. St-Onge studies the impact of lifestyle, specifically sleep and diet, on cardio-metabolic risk factors.

  • The Tall Laboratory is conducting research on the pathogenesis of metabolic diseases including atherosclerosis, obesity and fatty liver.

  • The Thaker Lab strives to identify rare and common genetic variants associated with severe early onset obesity in children of diverse ancestry

  • The Wolgemuth lab focuses on understanding the genetic control of gametogenesis and embryogenesis using mouse models and gene targeting, transgenic, and molecular and cell biological approaches.

  • Our focus is the translation of clinical and epidemiologic findings into early life interventions to eliminate racial/ethnic and socioeconomic disparities in childhood obesity and its co-morbidities.